Showing 17,041 - 17,060 results of 103,583 for search '(( i wt decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.06s Refine Results
  1. 17041

    Table_2_Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study.docx by Xiu Zhao (5334215)

    Published 2019
    “…Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.</p>Conclusion<p>Children with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. …”
  2. 17042
  3. 17043
  4. 17044
  5. 17045
  6. 17046
  7. 17047

    Effects of forced Elf5 expression on tumor growth and cell autonomous pro-tumorigenic traits. by David Gallego-Ortega (107516)

    Published 2016
    “…Labels are EGFP- (G-), EGFP+ (G+) and WT (W). Raw data for panels E, F, G, and H can be found in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002330#pbio.1002330.s001" target="_blank">S1 Data</a>.…”
  8. 17048
  9. 17049

    DataSheet_2_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.docx by Joaquin Garcia-Solorio (18296686)

    Published 2024
    “…</p>Results<p>We identified the IKZF1<sup>plus</sup> profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”
  10. 17050

    DataSheet_1_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.xlsx by Joaquin Garcia-Solorio (18296686)

    Published 2024
    “…</p>Results<p>We identified the IKZF1<sup>plus</sup> profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”
  11. 17051
  12. 17052
  13. 17053
  14. 17054

    Protein thiols, GSH and GSSG levles in bone marrow cells. by Jie Zhang (64655)

    Published 2014
    “…(<i>C)</i> Representative MALDI-MS images of GSH and GSSG in sectioned femur showing bone marrow distribution in WT and <i>Gstp1/p2</i><sup>−/−</sup> mice. …”
  15. 17055
  16. 17056

    Exposure to the Viral By-Product dsRNA or Coxsackievirus B5 Triggers Pancreatic Beta Cell Apoptosis via a Bim / Mcl-1 Imbalance by Maikel L. Colli (179059)

    Published 2011
    “…We have presently clarified the signaling pathways leading to beta cell apoptosis following exposure to the viral mimetic double-stranded RNA (dsRNA) and a diabetogenic enterovirus (Coxsackievirus B5). …”
  17. 17057

    Data_Sheet_1_NLRC5 Serves as a Pro-viral Factor During Influenza Virus Infection in Chicken Macrophages.docx by Shubhada K. Chothe (8678763)

    Published 2020
    “…In this study, we found that NLRC5 is activated by a range of low and highly pathogenic AIVs in primary chicken lung cells and a chicken macrophage cell line. …”
  18. 17058

    Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults by Prasad S. Kulkarni (12985371)

    Published 2024
    “…<p>AZD1222 (ChAdOx1 nCoV-19) is a replication-deficient adenoviral vectored coronavirus disease-19 (COVID-19) vaccine that is manufactured as SII-ChAdOx1 nCoV-19 by the Serum Institute of India Pvt Ltd following technology transfer from Oxford University/AstraZeneca. …”
  19. 17059
  20. 17060